Triluma Hydroquinone Usp 4% +Tretinoin Cream

Description

CAUTION: PRESCIPTION STRENGHT . CONSULT A SPECIALIST BEFORE USE.

TRI-LUMA^® (fluocinolone acetonide, hydroquinone, tretinoin) cream 0.01%/4%/0.05% is the only FDA-approved topical treatment available to help reduce the appearance of dark spots associated with moderate-to-severe facial melasma.¹

Triluma Cream is used to treat melasma. It helps in quick skin renewal. It provides relief from redness, swelling and itching . Melasma consists of dark (hyperpigmented) spots on facial skin, especially on the cheeks and forehead.

Warnings/Precautions: TRI-LUMA Cream contains sulfites which may cause severe, life-threatening allergic reactions in people allergic to sulfites. TRI-LUMA Cream contains hydroquinone, which may cause a gradual blue-black darkening of the skin. If you are pregnant, nursing or trying to become pregnant you should not use TRI-LUMA Cream. Safety and efficacy have not been established in individuals with darker skin. Reversible HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide, so discontinue use if signs and symptoms of this condition occur. Avoid products that may dry or irritate the skin, such as abrasive cleansers, scrubs, or skin-peeling agents. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided. If exposure cannot be avoided, sunscreen products [SPF 30 or more] and protective apparel should be used.